GitLife Biotech | Synthetic Biology & Bio-Digital Innovation GitLife Biotech was a pioneering deep-tech company developing innovative solutions for the identification, traceability and protection of engineered biological assets. Its flagship technology, CellRepo (GitLife), was a bio-digital platform designed to bring version control to biology — combining biological barcoding with digital traceability to establish provenance, protect intellectual property, enable secure collaboration and support biosecurity. Often described as "GitHub for Biology", the company's vision was to make biological innovation more transparent, traceable and secure, helping researchers and biotechnology companies manage and protect their valuable biological assets from early research through to commercialisation. GitLife Biotech has now ceased operations. This page remains as a record of the company's technology, vision and the contributions of those involved in its journey.
| Website | https://gitlifebiotech.com |
| Employees | 5 (3 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Synthetic Biology, Dna Sequencing, Reproducibility, Version Control System, Proof Of Ownership, Dna Analysis, Biotechnology Tools, Genetic Engineering, Genome Editing, Cell Engineering, Gene Synthesis, Biotechnology, Molecular Biology, Bioinformatics, Genetic Data, Data Management, Biological Research, Scientific Research, Life Sciences |
Looking for a particular GitLife Biotech employee's phone or email?
Harry Jackson is the Director of Synthetic Biology of GitLife Biotech.
3 people are employed at GitLife Biotech.
GitLife Biotech is based in Newcastle, England.